Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.41 | -17.67 |
PEG Ratio (TTM) | -0.80 | -5.55 |
P/S Ratio (TTM) | 1.72 | 39.21 |
P/B Ratio (TTM) | -18.40 | 5.85 |
P/FCF Ratio (TTM) | -1.77 | -147.35 |
Price to 5YR AVG Earnings Ratio | N/A | -34.54 |
Price to 5YR AVG FCF Ratio | N/A | -1.05 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -50.35% | 289.94% |
ROE (TTM) | -9,769.41% | -4,259.82% |
Net Profit Margin (TTM) | -119.24% | -1,048.46% |
ROIC 5YR AVG | N/A | -16.46% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.57% | -1,809.20% | N/A |
Revenue | -26.60% | -6.12% | N/A |
Net Income | -6.93% | 124.22% | N/A |
Cash Flow | -0.83% | 1,792.79% | N/A |
Health (11%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.59 | 4.95 |
Quick Ratio (TTM) | 0.59 | 4.93 |
D/E Ratio (TTM) | -6.39 | 1.30 |
Interest Coverage (TTM) | -36.45 | -11.54 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | N/A | 21.08 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 896.40% |